Skip Navigation

European Heart Journal 1984 5(10):834-841;
Copyright © 1984 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by IHLEN, H.
Right arrow Articles by OPSTAD, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by IHLEN, H.
Right arrow Articles by OPSTAD, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1984 The European Society of Cardiology

Evaluation of potential adverse effects of sodium nitroprusside during pacing-induced myocardial ischaemia in man

H. IHLEN, E. MYHRE and P. OPSTAD*

The Department of Medicine Rikshospitalet, Olso, Norway
*The Norwegian Defence Research Establishment, Division for Toxicology Kjeller, Norway

Received 6 April 1984; revised 12 June 1984; .

Abstract

To elucidate the potential harmful effects of sodium nitroprusside (NP) on myocardial ischaemia, eleven patients with coronary artery disease were studied before and during two doses NP infusion. The infusion rates were adjusted to reduce systolic aortic pressure by 10–20 mmHg and to between 100 and 110 mmHg. Myocardial haemodynamic and metabolic measurements were undertaken in sinus rhythm and during pacing-induced angina pectoris. The procedure was repeated at the low and high dose NP using the same pacing rate. One patient did not develop ischaemia and was excluded. Low dose NP reduced ischaemia slightly, whereas the higher dose had no effect despite falling indices of cardiac work. The oxygen uptake was maintained except at high dose treatment during pacing due to an increased catecholamine stimulation. The transmural perfusion gradient was unchanged at low dose NP, but fell at the higher dose suggesting reduced perfusion of ischaemic tissue. High dose NP also decreased coronary arteriolar resistance considerably which may have induced a coronary ‘steal’ effect. Thus, NP may induce adverse haemodynamic and metabolic changes which counteract the beneficial actions of the drug on ischaemia when used in high doses and in patients without heart failure.

Key Words: Cardiac venous flow • coronary artery disease • lactate • myocardial ischaemia • sodium nitroprusside


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 NEJMHome page
P. K. Agarwal, R. Kumari, G. Karthikeyan, A. Gogbashian, U. N. Khot, G. M. Novaro, and G. S. Francis
Nitroprusside in Critically Ill Patients with Aortic Stenosis
N. Engl. J. Med., August 21, 2003; 349(8): 811 - 813.
[Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.